The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,219.00
Bid: 2,216.00
Ask: 2,218.00
Change: 41.00 (1.88%)
Spread: 2.00 (0.09%)
Open: 2,196.00
High: 2,223.00
Low: 2,182.00
Prev. Close: 2,178.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Sep 2018 07:00

RNS Number : 0655C
Halma PLC
27 September 2018
 

 

Halma plc

 

Trading Update

 

27 September 2018

 

 

Halma, the leading safety, health and environmental technology group, today releases its scheduled trading update, for the period from 1 April 2018 to date.

 

Halma made good progress in this period, in line with the Board's expectations.

 

All sectors delivered organic constant currency revenue and profit growth. Order intake was ahead of revenue and also ahead of the same period last year.

 

The Medical and Environmental & Analysis sectors delivered strong growth, with Medical continuing to benefit from the actions taken to improve profitability in the second half of last year. Process Safety and Infrastructure Safety continued to perform well, even though the Process Safety performance included some modest re-organisation costs.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. The USA grew strongly, and all other regions saw good rates of growth.

 

Cash generation remained strong. This, together with Halma's robust financial position, will support continued investment in growth, both organically and by acquisition.

 

We have a good acquisition pipeline and our M&A teams continue to be active. We made three small, technologically-driven bolt-on acquisitions in the period, for a maximum total consideration of £3 million.

 

The results for the half year ending 30 September 2018 will be released on 20 November 2018.

 

For further information, please contact:

 

 

Halma plc

 

Andrew Williams, Chief Executive

On 27 September: +44 (0)7776 685948

Marc Ronchetti, Chief Financial Officer

Thereafter: +44 (0)1494 721111

Charles King, Head of Investor Relations

 

 

MHP Communications

 

Rachel Hirst/ Andrew Jaques

+44 (0)20 3128 8100

 

 

 

About Halma

 

Halma is a market leader in specialist safety, health and environmental technologies, creating a safer, cleaner and healthier future for people worldwide. We target markets where sustainable growth and high returns are supported by long-term drivers. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 6,000 people in 20 countries, with major operations in Europe, the USA and Asia-Pacific. In the year to 31 March 2018, the Group's revenues exceeded £1bn for the first time. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes:

 

1. This Trading Update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

2. The Medical sector disposed of the Accudynamics fluid technology business for US$5m, resulting in a small loss on disposal of US$1.6m. The original US$31.8m consideration on acquisition in Dec 2010 primarily related to goodwill (regarding our, ultimately successful, ability to develop the product offering of other fluid technology businesses across the Halma group) and customer intangibles.

 

3. The Finance Director succession was completed as planned in the period, with Marc Ronchetti starting as Halma's Chief Financial Officer on 1 July 2018, following an extensive handover process. In other senior moves, Carol Chesney, Company Secretary, will leave Halma after 23 years at the end of September 2018 to focus on her non-executive appointments, with a new General Counsel and Company Secretary expected to be appointed in early 2019, and Charles King joined as Head of Investor Relations earlier this month.

4. A copy of this announcement, together with other information about Halma, may be viewed on its website at www.halma.com

Ends

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBUGDCSUDBGIL
Date   Source Headline
9th May 20142:28 pmRNSHolding(s) in Company
1st May 20142:45 pmRNSTotal Voting Rights
22nd Apr 20144:00 pmRNSHolding(s) in Company
2nd Apr 201412:00 pmRNSTotal Voting Rights
4th Mar 20143:53 pmRNSTreasury Stock
3rd Mar 20143:11 pmRNSTotal Voting Rights
11th Feb 20146:06 pmRNSDirector/PDMR Shareholding
11th Feb 20147:00 amRNSInterim Management Statement
5th Feb 20141:08 pmRNSDirector/PDMR Shareholding
3rd Feb 20144:31 pmRNSTotal Voting Rights
23rd Jan 20144:20 pmRNSHolding(s) in Company
14th Jan 20143:34 pmRNSTreasury Stock
7th Jan 201410:34 amRNSBlocklisting Interim Review
2nd Jan 201411:36 amRNSTotal Voting Rights
3rd Dec 20139:58 amRNSTreasury Stock
2nd Dec 20135:19 pmRNSTotal Voting Rights
2nd Dec 20135:04 pmRNSTreasury Stock
2nd Dec 20135:00 pmRNSDirector Declaration
29th Nov 20137:00 amRNSRevolving Credit Facility
27th Nov 201311:11 amRNSDirector/PDMR Shareholding
19th Nov 20131:32 pmRNSDoc re. Half Yearly Report
19th Nov 20137:00 amRNSHalf Yearly Report
8th Nov 201312:58 pmRNSNotice of Results
4th Nov 201311:14 amRNSTotal Voting Rights
3rd Oct 20131:59 pmRNSDirector/PDMR Shareholding
1st Oct 20132:39 pmRNSTotal Voting Rights
23rd Sep 201311:02 amRNSTreasury Stock
17th Sep 20133:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20139:46 amRNSTotal Voting Rights
22nd Aug 201311:52 amRNSTreasury Stock
16th Aug 20139:00 amRNSAnnual Information Update
7th Aug 20139:04 amRNSShare Transactions and Purchase of Own Shares
1st Aug 20133:12 pmRNSTotal Voting Rights
30th Jul 201312:08 pmRNSBlocklisting Interim Review
26th Jul 20133:22 pmRNSResult of AGM
25th Jul 20137:00 amRNSInterim Management Statement
5th Jul 20131:57 pmRNSDirector/PDMR Shareholding
1st Jul 201311:43 amRNSTotal Voting Rights
25th Jun 201312:23 pmRNSAnnual Financial Report
21st Jun 20131:26 pmRNSTreasury Stock
13th Jun 20137:17 amRNSFinal Results
3rd Jun 20139:39 amRNSTotal Voting Rights
30th May 201311:15 amRNSNotice of Results
20th May 20135:24 pmRNSTreasury Stock
1st May 201310:35 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSInvestor Site Visit and Trading Update
19th Apr 201311:27 amRNSTransaction in Own Shares
11th Apr 20139:00 amRNSDirectorate Change
8th Apr 201311:15 amRNSTreasury Stock
3rd Apr 201310:22 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.